BIOMAT Database Logo BIOMAT Database Logo

Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies. 1991

P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Fred Hutchinson Cancer Research Center, Seattle, Washington.

Less than 40% of the patients who could benefit from marrow transplantation have an HLA-matched relative who can serve as a donor. For this reason, several centers have explored marrow transplantation from other categories of donors. This retrospective study analyzes the results of marrow transplantation for 52 patients receiving grafts from HLA-A,B,DR,Dw-phenotypically matched, MLC-compatible, unrelated volunteer donors compared to a disease, disease-stage, and age-matched cohort of 104 patients transplanted from HLA-genotypically identical sibling donors. The patients transplanted from unrelated donors had an increased incidence of grade II-IV acute graft-versus-host disease compared to patients transplanted from related donors (79% vs. 36%, P much less than 0.001). However, the probability of relapse-free survival appears similar in the two groups (P = 0.39 over all, with estimates of 41% vs. 46% at 1 year). We conclude from this preliminary data that marrow transplantation from HLA-matched unrelated donors should be considered in most, if not all, circumstances where transplantation from an HLA-matched sibling would be indicated if such a donor were available.

UI MeSH Term Description Entries
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D014019 Tissue Donors Individuals supplying living tissue, organs, cells, blood or blood components for transfer or transplantation to histocompatible recipients. Organ Donors,Donors,Ovum Donors,Semen Donors,Transplant Donors,Donor,Donor, Organ,Donor, Ovum,Donor, Semen,Donor, Tissue,Donor, Transplant,Donors, Organ,Donors, Ovum,Donors, Semen,Donors, Tissue,Donors, Transplant,Organ Donor,Ovum Donor,Semen Donor,Tissue Donor,Transplant Donor

Related Publications

P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Bone marrow transplantation from HLA-matched unrelated donors as treatment for leukemia.
January 1993, Journal of hematotherapy,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Bone marrow transplantation utilizing HLA-matched unrelated marrow donors.
June 1990, Blood reviews,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Bone marrow transplantation for leukemia utilizing HLA-matched unrelated donors.
January 1993, Bone marrow transplantation,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies.
February 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.
February 2011, Hematology/oncology clinics of North America,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency.
February 2010, Immunology and allergy clinics of North America,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies.
April 1998, Bone marrow transplantation,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
Unrelated donor marrow transplantation for treatment of childhood hematologic malignancies-effect of HLA disparity and cell dose.
January 1999, Cancer treatment and research,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.
September 2003, Blood,
P G Beatty, and J A Hansen, and G M Longton, and E D Thomas, and J E Sanders, and P J Martin, and S I Bearman, and C Anasetti, and E W Petersdorf, and E M Mickelson
In vitro methods and selection of HLA-matched unrelated donors for bone marrow transplantation.
February 1991, Transplantation proceedings,
Copied contents to your clipboard!